Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

13.33
-0.4900-3.55%
Post-market: 13.430.1000+0.75%19:59 EDT
Volume:2.08M
Turnover:28.33M
Market Cap:1.84B
PE:-3.69
High:14.02
Open:13.82
Low:13.30
Close:13.82
52wk High:15.40
52wk Low:4.29
Shares:138.00M
Float Shares:107.00M
Volume Ratio:0.92
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:21.76
PE(LYR):-4.33

Loading ...

Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check. -- Barrons.com

Dow Jones
·
Apr 24

Stock Track | COMPASS Pathways Soars 5.03% Intraday on FDA Fast-Tracking Psychedelic Drug Research and Regulatory Progress

Stock Track
·
Apr 24

BUZZ-U.S. STOCKS ON THE MOVE-Zoom, Compass Pathways,  X-Energy

Reuters
·
Apr 24

Compass Pathways Says Rolling Review Request Granted by FDA

MT Newswires Live
·
Apr 24

Compass Pathways announces FDA granted NDA rolling review request

TIPRANKS
·
Apr 24

Compass Pathways Plc - Cnpv Program Provides Shortened 1-2 Month Review Time After Nda Filing

THOMSON REUTERS
·
Apr 24

Compass Pathways Plc - Awarded Cnpv for Comp360 for Treatment-Resistant Depression

THOMSON REUTERS
·
Apr 24

Compass Pathways Announces FDA Granted Nda Rolling Review Request and Awarded Commissioner's National Priority Voucher

THOMSON REUTERS
·
Apr 24

BUZZ-Compass Pathways rises after FDA fast-tracks psychedelic drug research

Reuters
·
Apr 24

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS
·
Apr 24

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS
·
Apr 24

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS
·
Apr 24

Compass Pathways Initiated at Buy by B. Riley Securities

Dow Jones
·
Apr 24

B. Riley Initiates COMPASS Pathways at Buy With $17 Price Target

MT Newswires Live
·
Apr 24

Stock Track | Compass Pathways Soars 7.21% in Pre-market After B. Riley Initiates Coverage with Buy Rating and $17 Target

Stock Track
·
Apr 24

Compass Pathways initiated with a Buy at B. Riley

TIPRANKS
·
Apr 24

Compass Pathways Plc : B. Riley Initiates Coverage With Buy Rating; Target Price $17

THOMSON REUTERS
·
Apr 24

EXPLAINER-What to know about psychedelic therapies cited by Trump

Reuters
·
Apr 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Apr 21

Compass Pathways enters collaboration with Osmind

TIPRANKS
·
Apr 21